Artisan Partners Limited Partnership Verastem, Inc. Transaction History

Artisan Partners Limited Partnership

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.33 - $10.44 $2,319 - $73,382	7,029 Added 0.37%	1,920,298 $768,000
Q3 2022 Nov 10, 2022	SELL	$0.92 - $11.16 $5,059 - $61,368	-5,499 Reduced 0.29%	1,913,269 $1.63 Million
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $25,870 - $46,414	-25,363 Reduced 1.3%	1,918,768 $2.23 Million
Q1 2022 May 13, 2022	BUY	$1.06 - $2.1 $32,858 - $65,097	30,999 Added 1.62%	1,944,131 $2.74 Million
Q4 2021 Feb 11, 2022	SELL	$2.05 - $3.2 $21,902 - $34,188	-10,684 Reduced 0.56%	1,913,132 $3.92 Million
Q3 2021 Nov 12, 2021	BUY	$2.54 - $4.07 $216,877 - $347,516	85,385 Added 4.64%	1,923,816 $5.93 Million
Q2 2021 Aug 12, 2021	BUY	$2.57 - $4.85 $4.72 Million - $8.92 Million	1,838,431 New	1,838,431 $7.48 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.